LPL Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.23M | Sell |
152,042
-18,789
| -11% | -$991K | ﹤0.01% | 2297 |
|
|
2025
Q4 | $8.96M | Sell |
170,831
-40,230
| -19% | -$2.41M | ﹤0.01% | 2032 |
|
|
2025
Q3 | $13.7M | Buy |
211,061
+16,482
| +8% | +$946K | ﹤0.01% | 1616 |
|
|
2025
Q2 | $9.46M | Buy |
194,579
+9,121
| +5% | +$353K | ﹤0.01% | 1772 |
|
|
2025
Q1 | $6.31M | Buy |
185,458
+35,732
| +24% | +$1.51M | ﹤0.01% | 1959 |
|
|
2024
Q4 | $5.89M | Buy |
149,726
+42,232
| +39% | +$1.99M | ﹤0.01% | 1938 |
|
|
2024
Q3 | $5.05M | Sell |
107,494
-8,597
| -7% | -$436K | ﹤0.01% | 1983 |
|
|
2024
Q2 | $6.27M | Buy |
116,091
+10,171
| +10% | +$588K | ﹤0.01% | 1691 |
|
|
2024
Q1 | $7.22M | Buy |
105,920
+13,459
| +15% | +$963K | ﹤0.01% | 1537 |
|
|
2023
Q4 | $5.79M | Buy |
92,461
+1,662
| +2% | +$91.9K | ﹤0.01% | 1592 |
|
|
2023
Q3 | $4.12M | Buy |
90,799
+46
| +0.1% | +$2.38K | ﹤0.01% | 1709 |
|
|
2023
Q2 | $5.09M | Buy |
90,753
+9,040
| +11% | +$513K | ﹤0.01% | 1551 |
|
|
2023
Q1 | $3.7M | Buy |
81,713
+3,828
| +5% | +$186K | ﹤0.01% | 1695 |
|
|
2022
Q4 | $3.17M | Sell |
77,885
-274
| -0.4% | -$14.5K | ﹤0.01% | 1737 |
|
|
2022
Q3 | $5.11M | Buy |
78,159
+6,140
| +9% | +$445K | ﹤0.01% | 1365 |
|
|
2022
Q2 | $4.38M | Buy |
72,019
+6,647
| +10% | +$391K | ﹤0.01% | 1498 |
|
|
2022
Q1 | $4.1M | Buy |
65,372
+13,240
| +25% | +$831K | ﹤0.01% | 1563 |
|
|
2021
Q4 | $3.95M | Sell |
52,132
-3,286
| -6% | -$287K | ﹤0.01% | 1612 |
|
|
2021
Q3 | $6.2M | Buy |
55,418
+5,788
| +12% | +$727K | 0.01% | 1250 |
|
|
2021
Q2 | $8.04M | Buy |
49,630
+3,324
| +7% | +$404K | 0.01% | 1041 |
|
|
2021
Q1 | $5.64M | Sell |
46,306
-10,226
| -18% | -$1.54M | 0.01% | 1148 |
|
|
2020
Q4 | $8.66M | Buy |
56,532
+19,840
| +54% | +$2.35M | 0.01% | 817 |
|
|
2020
Q3 | $3.07M | Sell |
36,692
-20,636
| -36% | -$1.83M | ﹤0.01% | 1209 |
|
|
2020
Q2 | $4.21M | Buy |
57,328
+35,131
| +158% | +$2.05M | 0.01% | 964 |
|
|
2020
Q1 | $941K | Buy |
22,197
+3,363
| +18% | +$174K | ﹤0.01% | 1656 |
|
|
2019
Q4 | $1.15M | Buy |
18,834
+5,729
| +44% | +$313K | ﹤0.01% | 1728 |
|
|
2019
Q3 | $537K | Sell |
13,105
-20,193
| -61% | -$965K | ﹤0.01% | 2209 |
|
|
2019
Q2 | $1.57M | Buy |
33,298
+25,047
| +304% | +$1M | ﹤0.01% | 1390 |
|
|
2019
Q1 | $295K | Sell |
8,251
-1,558
| -16% | -$53.9K | ﹤0.01% | 2647 |
|
|
2018
Q4 | $280K | Buy |
9,809
+1,924
| +24% | +$66.9K | ﹤0.01% | 2517 |
|
|
2018
Q3 | $350K | Buy |
7,885
+1,138
| +17% | +$59.6K | ﹤0.01% | 2540 |
|
|
2018
Q2 | $396K | Buy |
6,747
+1,137
| +20% | +$64.8K | ﹤0.01% | 2400 |
|
|
2018
Q1 | $256K | Buy |
+5,610
| New | +$232K | ﹤0.01% | 2764 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
